Prakash Raman
Direttore/Membro del Consiglio presso BLACK DIAMOND THERAPEUTICS, INC.
Patrimonio netto: 10 999 $ in data 31/05/2024
Profilo
Prakash Raman is currently the Chief Executive Officer at Indupro and an Independent Director at Black Diamond Therapeutics, Inc. He is also a Director at NAYA Biosciences, Inc. Previously, he served as the Co-Chief Executive Officer & Director at KSQ Therapeutics, Inc. and as the President, Chief Executive Officer & Director at Ribon Therapeutics, Inc. Dr. Raman was also the VP & Global Head-NIBR Business Development at Novartis Institutes for Biomedical Research, Inc. He started his career as the Head-Project Management at AstraZeneca PLC.
Dr. Raman holds a doctorate degree from the University of Wisconsin and an undergraduate degree from the Indian Institute of Technology Bombay.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 21/06/2024 | 2 301 ( 0.00% ) | 10 999 $ | 31/05/2024 |
Posizioni attive di Prakash Raman
| Società | Posizione | Inizio |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 10/04/2024 |
| Indupro | Amministratore Delegato | 13/06/2024 |
Precedenti posizioni note di Prakash Raman
| Società | Posizione | Fine |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/11/2012 |
KSQ Therapeutics, Inc.
 KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Amministratore Delegato | - |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Amministratore Delegato | - |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Prakash Raman
| Indian Institute of Technology Bombay | Undergraduate Degree |
| University of Wisconsin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| ASTRAZENECA PLC | Health Technology |
| Aziende private | 4 |
|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology KSQ Therapeutics, Inc. develops and deploys precision functional genomics to discover therapies that transform patient lives. The company was founded by Tim Wang and is headquartered in Cambridge, MA. | Health Technology |
Ribon Therapeutics, Inc.
Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Health Technology |
| Indupro |
- Borsa valori
- Insiders
- Prakash Raman
